US5013560A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Microbially-stable bismuth-containing liquid pharmaceutical suspensions
Assignee: Procter and Gamble Co
•
Filing: 1989-03-17
•
Granted: 1991-05-07
•
Expires: 2009-03-17
Abstract
Abstract Microbially-stable liquid pharmaceutical suspensions for oral administration comprising a bismuth-containing pharmaceutical agent, benzoic acid, sorbic acid, a suspension system and water, and wherein said compositions have a pH within the range of from about 3.0 to about 5.5. These compositions are efficacious, and have good aesthetics and good storage stability.
Inventors
- 👤 Laura L. Stentz
- 👤 Jerry R. Maney
- 👤 Thomas E. Sox
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 16:34
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A61K31/00; A61K31/28; A61K31/29; A61K31/60
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
79 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 0.1% to about 10% of a bismuth-containing pharmaceutical agent; (b) from about 0.01% to about 0.075% of benzoic acid; (c) from about 0.01% to about 0.04% of sorbic acid; (d) from about 0.1% to about 10% of a suspension system; and (e) from about 80% to about 99% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 5.5.
Claim 2
Dependent Claim
79 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 0.1% to about 10% of a bismuth-containing pharmaceutical agent; (b) from about 0.01% to about 0.075% of benzoic acid; (c) from about 0.01% to about 0.04% of sorbic acid; (d) from about 0.1% to about 10% of a suspension system; and (e) from about 80% to about 99% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 5.5.
Claim 3
Dependent Claim
41 words
Microbially-stable liquid pharmaceutical suspensions according to claim 1 wherein said bismuth-containing agent is selected from the group consisting of bismuth aluminate, bismuth subcarbonate, bismuth subcitrate, bismuth citrate, tripotassium dicitrato bismuthate, bismuth subgalate, bismuth subnitrate, bismuth tartrate, bismuth subsalicylate, and mixtures thereof.
Claim 4
Dependent Claim
27 words
Microbially-stable liquid pharmaceutical suspensions according to claim 1 wherein said suspension system comprises a pharmaceutically-acceptable non-ionic cellulose ether polymer, magnesium aluminum silicate, xanthan gum, or mixtures thereof.
Claim 5
Dependent Claim
34 words
Microbially-stable liquid pharmaceutical suspensions according to claim 2 wherein said bismuth-containing pharmaceutical agent is selected from the group consisting of bismuth citrate, bismuth subcitrate, tripotassium dicitrato bismuthate, bismuth tartrate, bismuth subsalicylate, and mixtures thereof.
Claim 6
Dependent Claim
34 words
Microbially-stable liquid pharmaceutical compositions according to claim 4 wherein said suspension system is selected from the group consisting of methylcellulose, hydroxypropylmethylcellulose, hydroxybutylmethylcellulose, hydroxyethylmethylcellulose, ethylhydroxyethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, xanthan gum, magnesium aluminum silicate, and mixtures thereof.
Claim 7
Dependent Claim
19 words
Microbially-stable liquid pharmaceutical suspensions according to claim 2 wherein said suspension system comprises xanthan gum and magnesium aluminum silicate.
Claim 8
Dependent Claim
18 words
Microbially-stable liquid pharmaceutical suspensions according to claim 2 wherein said suspension system comprises methylcellulose and magnesium aluminum silicate.
Claim 9
Dependent Claim
108 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 0.5% to about 5% of a bismuth-containing pharmaceutical agent selected from the group consisting of bismuth subcitrate, bismuth subsalicylate, and mixtures thereof; (b) from about 0.01% to about 0.06% of benzoic acid; (c) from about 0.01% to about 0.03% of sorbic acid; (d) from about 0.5% to about 5% of a suspension system selected from the group consisting of non-ionic cellulose ether polymer, magnesium aluminum silicate, and mixtures thereof; and (e) from about 90% to about 99% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 4.2.
Claim 10
Dependent Claim
108 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 0.5% to about 5% of a bismuth-containing pharmaceutical agent selected from the group consisting of bismuth subcitrate, bismuth subsalicylate, and mixtures thereof; (b) from about 0.01% to about 0.06% of benzoic acid; (c) from about 0.01% to about 0.03% of sorbic acid; (d) from about 0.5% to about 5% of a suspension system selected from the group consisting of non-ionic cellulose ether polymer, magnesium aluminum silicate, and mixtures thereof; and (e) from about 90% to about 99% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 4.2.
Claim 11
Dependent Claim
16 words
Microbially-stable liquid pharmaceutical suspensions according to claim 8 wherein said bismuth-containing pharmaceutical agent is bismuth subcitrate.
Claim 12
Dependent Claim
16 words
Microbially-stable liquid pharmaceutical suspensions according to claim 8 wherein said bismuth-containing pharmaceutical agent is bismuth subsalicylate.
Claim 13
Dependent Claim
18 words
Microbially-stable liquid pharmaceutical suspensions according to claim 9 wherein said suspension system comprises methylcellulose and magnesium aluminum silicate.
Claim 14
Dependent Claim
18 words
Microbially-stable liquid pharmaceutical suspensions according to claim 10 wherein said suspension system comprises methylcellulose and magnesium aluminum silicate.
Claim 15
Dependent Claim
102 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 1% to about 4% of a bismuth-containing pharmaceutical agent selected from the group consisting of bismuth subcitrate, bismuth subsalicylate, and mixtures thereof; (b) from about 0.025% to about 0.05% of benzoic acid; (c) from about 0.0125% to about 0.025% of sorbic acid; (d) from about 1% to about 3% of a suspension system, wherein said suspension system comprises methylcellulose and magnesium aluminum silicate; and (e) from about 93% to about 98% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 4.2.
Claim 16
Dependent Claim
102 words
Microbially-stable liquid pharmaceutical suspensions for oral administration comprising: (a) from about 1% to about 4% of a bismuth-containing pharmaceutical agent selected from the group consisting of bismuth subcitrate, bismuth subsalicylate, and mixtures thereof; (b) from about 0.025% to about 0.05% of benzoic acid; (c) from about 0.0125% to about 0.025% of sorbic acid; (d) from about 1% to about 3% of a suspension system, wherein said suspension system comprises methylcellulose and magnesium aluminum silicate; and (e) from about 93% to about 98% water, and wherein further said liquid composition has a pH within the range of from about 3.0 to about 4.2.
Claim 17
Dependent Claim
16 words
Microbially-stable liquid pharmaceutical suspension according to claim 13 wherein said bismuth-containing pharmaceutical agent is bismuth subcitrate.
Claim 18
Dependent Claim
16 words
Microbially-stable liquid pharmaceutical suspension according to claim 13 wherein said bismuth-containing pharmaceutical agent is bismuth subsalicylate.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-05-06 | 1994-11-05 | 1995-05-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-05-06 | 1998-11-05 | 1999-05-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-05-06 | 2002-11-05 | 2003-05-07 | $7700.00 | Window Closed / Lapsed |